Cancers of the Head and Neck Completed Phase 1 / 2 Trials for Everolimus (DB01590)

Also known as: Cancer of the Head and Neck

IndicationStatusPhase
DBCOND0065283 (Cancers of the Head and Neck)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01283334A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck CancerTreatment